Retraction
Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines
Paper Information
Record ID:
59335
Author(s):
Publication Date:
April 27, 2022
Retraction Date:
December 13, 2023
(1.9 year years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations0
Post-Retraction3
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer
Donghan Xu, Yehao Luo, Peng Wang et al. (12 authors)
Frontiers in Oncology
Open Access
Published: Jun 2023
4 citations
4 citations
184 days before retraction
Retracted: Efficacy of Apatinib plus S‐1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2‐Like Cytokines
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
346 days before retraction
Study on the Application Value of Concurrent Chemoradiotherapy and Clinical Nursing Pathway for Postoperative Patients with Esophageal Cancer
Jinglei Yang, Xianzhong Zhang, Guangrong Yang et al. (6 authors)
Journal of Oncology
Open Access
Published: Sep 2022
1 citation
1 citation
454 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025